BCL2 and osteosarcoma: Osteosarcoma cells were extremely sensitive to dual inhibition of MCL-1 and BCL-xL, as evidenced by rapid apoptosis at low concentrations (Fig. 2), whilst combined BCL-xL and BCL-2 antagonism had minimal impact on cell viability.